William J. Wechter
26Patents
12h-index
18Co-inventors
78Inventor score
Filing activity: Mar 15, 1974 → Oct 3, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6150402A | Natriuretic compounds | Chemistry; Metallurgy | 48 | Expired |
| US6083982A | Natriuretic compounds | Chemistry; Metallurgy | 43 | Expired |
| US5955504A | Colorectal chemoprotective composition and method of preventing colorectal cancer | Human Necessities | 41 | Expired |
| US6242479A | Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease | Human Necessities | 41 | Expired |
| US5331000A | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen | Human Necessities | 40 | Expired |
| US6048891A | Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of natriuretic disease | Human Necessities | 34 | Expired |
| US5981592A | Method and composition for treating cystic fibrosis | Human Necessities | 25 | Expired |
| US3975367A | Arabinofuranosyl N.sup.4 -aminoacyl cytosine containing compounds | Chemistry; Metallurgy | 21 | Expired |
| US4096324A | Cytidine nucleoside compound | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7074826B2 | R-NSAID esters and their use | Chemistry; Metallurgy | 16 | Expired |
| US6160018A | Prophylactic composition and method for alzheimer's Disease | Human Necessities | 16 | Expired |
| US5561151A | Antipyretic and analgesic methods of using optically pure R-etodolac | Human Necessities | 14 | Expired |
| US6410589B1 | Use of &ggr;-tocopherol and its oxidative metabolite LLU-&agr; in the treatment of disease | Human Necessities | 12 | Expired |
| US5190981A | Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease | Human Necessities | 12 | Expired |
| US6555575B2 | Use of &ggr;-tocopherol and its oxidative metabolite LLU-&agr; in the treatment of disease | Human Necessities | 10 | Expired |
| US5422393A | Natriuretic hormone | Human Necessities | 8 | Expired |
| US5382591A | Antipyretic and analgesic methods using optically pure R-ketorolac | Human Necessities | 8 | Expired |
| US3953468A | 3-Cyano thiophen-2-yl oxamic acid and derivatives | Chemistry; Metallurgy | 7 | Expired |
| US6472433B2 | Method for treatment of inflammation with R-NSAIDS | Human Necessities | 6 | Expired |
| US4172889A | Method of treating rheumatoid arthritis | Chemistry; Metallurgy | 5 | Expired |
| US4118484A | Method of treating rheumatoid arthritis | Chemistry; Metallurgy | 5 | Expired |
| US5106630A | Natriuretic hormone | Human Necessities | 4 | Expired |
| US4501754A | Methods of treating bone resorption | Human Necessities | 4 | Expired |
| US4145414A | Organic compounds and compositions of ara-cytidine | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5846967A | Natriuretic and anti-hypertensive compounds | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.